Superior parietal cortex and the attention to delayed intention: An rTMS study.

This study aimed to investigate whether the superior parietal cortex is causally involved in PM and, if so, what is its functional role. We applied repetitive transcranial magnetic stimulation (rTMS) to the left and right superior parietal cortex, and we evaluated the TMS effects on two different PM tasks that required to direct the attention towards either the external stimuli (\u2018Monitoring-load\u2019 task) or the intention in memory (\u2018Retrospective-load\u2019 task). rTMS of left parietal cortex produced a facilitation of PM performance in both tasks. This was coupled by slower responses to the ongoing activity, for left and right parietal stimulation, but selectively in the \u2018Retrospective-load\u2019 condition. The present results suggest that superior parietal cortex is causally involved in biasing top-down attentional resources between the external, ongoing stimuli and the internal, PM intentions. The possible physiological mechanisms underlying the TMS-related improvement in PM performance are discussed

Non-refoulement e "Sistema Dublino"

Partendo dall’individuazione del rapporto esistente tra il diritto internazionale dei rifugiati e il diritto internazionale dei diritti umani e della conseguente sempre maggiore rilevanza che la figura del “rifugiato” assume nel contesto dello studio dei diritti umani, si è proceduto a delineare i momenti salienti dell’affermazione ed estensione in via pretoria, da parte della Corte europea dei diritti dell’uomo, del principio di non-refoulement, storicamente a tutela dei rifugiati, nel testo della Convenzione di Roma del 1950 e in particolare nel suo articolo 3 che contiene il divieto di tortura e trattamenti inumani o degradanti. Spostandosi nella realtà dell’Unione europea, si è descritto il percorso che ha condotto all’affermazione di una competenza comunitaria in materia di asilo, si sono individuati gli strumenti normativi più significativi adottati nell’esercizio di tale competenza soffermandosi tuttavia principalmente sul regolamento “Dublino II” relativo all’individuazione dei criteri per la determinazione della competenza ad esaminare una domanda di asilo, del quale si sono ricostruite le origini e le recenti evoluzione. Infine, seguendo il cammino tracciato dalle pronunce della giurisprudenza europea, della Corte di Strasburgo, ma anche della Corte di giustizia dell’unione europea, si sono individuati i profili di incompatiblità del “Sistema Dublino” rispetto al principio di non-refoulement come ormai rinvenibile nell’articolo 3 della Convenzione europea dei diritti dell’uomo nonchè l’incidenza, a questo proposito, delle recenti modifiche ad esso apportate

Correction: High piezo-resistive performances of anisotropic composites realized by embedding rGO-based chitosan aerogels into open cell polyurethane foams

Correction for 'High piezo-resistive performances of anisotropic composites realized by embedding rGO-based chitosan aerogels into open cell polyurethane foams' by Tianliang Zhai et al., Nanoscale, 2019, 11, 8835–8844

Processed Animal Proteins from Insect and Poultry By-Products in a Fish Meal-Free Diet for Rainbow Trout: Impact on Intestinal Microbiota and Inflammatory Markers

Sustainability of aquaculture is tied to the origin of feed ingredients. In search of sustainable fish meal-free formulations for rainbow trout, we evaluated the effect of Hermetia illucens meal (H) and poultry by-product meal (P), singly (10, 30, and 60% of either H or P) or in combination (10% H + 50% P, H10P50), as partial replacement of vegetable protein (VM) on gut microbiota (GM), inflammatory, and immune biomarkers. Fish fed the mixture H10P50 had the best growth performance. H, P, and especially the combination H10P50 partially restored \u3b1-diversity that was negatively affected by VM. Diets did not differ in the Firmicutes:Proteobacteria ratio, although the relative abundance of Gammaproteobacteria was reduced in H and was higher in P and in the fishmeal control. H had higher relative abundance of chitin-degrading Actinomyces and Bacillus, Dorea, and Enterococcus. Actinomyces was also higher in H feed, suggesting feed-chain microbiome transmission. P increased the relative abundance of protein degraders Paeniclostridium and Bacteroidales. IL-1\u3b2, IL-10, TGF-\u3b2, COX-2, and TCR-\u3b2 gene expression in the midgut and head kidney and plasma lipopolysaccharide (LPS) revealed that the diets did not compromise the gut barrier function or induce inflammation. H, P, and H10P50 therefore appear valid protein sources in fishmeal-free aquafeeds

Protein hunger of the feed sector: the alternatives offered by the plant world

The expected future demand for highly nutrient animal food products will push the animal production system to search for new sources of high-quality protein feedstuffs. In this scenario, economic and environmental issues will have to be considered while reducing the competition with the plant-based human food chains. Legume grains and some oilseed cakes, by-products from the oil industry, are the main protein sources for ruminants and terrestrial monogastrics such as pigs and poultry. Their relevant role will hold in the next decades, but it is necessary to increase the diversification of sources that can be grown profitably throughout the world, including European countries. Microalgae are a promising source of protein and other nutrients for animal feeding. However, an amazing richness of biologically active substances makes these organisms very interesting as feed ingredients, as their role go far beyond the supply of nutrients. Due to the limited usage of microalgae as human foodstuffs or food ingredients, low competition between microalgae-based feed and food chains is predictable. This review aims to synthesise current knowledge on minor pulses and other protein-rich plant products and microalgae, as alternative ingredients to the conventional animal protein sources, focussing on their production, availability, and nutritional values. Points of strength, weakness, opportunity and threat related to the use of these protein sources in animal feeding are separately analysed through a SWOT approach to underlie future needs in terms of research and/or technological development that could help valorise these nutrient sources as feed ingredients

Growth and Welfare of Rainbow Trout (Oncorhynchus mykiss) in Response to Graded Levels of Insect and Poultry By-Product Meals in Fishmeal-Free Diets

This study compared the nutrient-energy retention, digestive function, growth performance, and welfare of rainbow trout (ibw 54 g) fed isoproteic (42%), isolipidic (24%), fishmeal-free diets (CV) over 13 weeks. The diets consisted of plant-protein replacement with graded levels (10, 30, 60%) of protein from poultry by-product (PBM) and black soldier fly H. illucens pupae (BSFM) meals, either singly or in combination. A fishmeal-based diet was also tested (CF). Nitrogen retention improved with moderate or high levels of dietary PBM and BSFM relative to CV (p < 0.05). Gut brush border enzyme activity was poorly affected by the diets. Gastric chitinase was up-regulated after high BSFM feeding (p < 0.05). The gut peptide and amino acid transport genes were differently regulated by protein source and level. Serum cortisol was unaffected, and the changes in metabolites stayed within the physiological range. High PBM and high BSFM lowered the leukocyte respiratory burst activity and increased the lysozyme activity compared to CV (p < 0.05). The BSFM and PBM both significantly changed the relative percentage of lymphocytes and monocytes (p < 0.05). In conclusion, moderate to high PBM and BSFM inclusions in fishmeal-free diets, either singly or in combination, improved gut function and nutrient retention, resulting in better growth performance and the good welfare of the rainbow trout

Cetuximab continuation after first progression in metastatic colorectal cancer (CAPRI-GOIM): A randomized phase II trial of FOLFOX plus cetuximab versus FOLFOX

Background: Cetuximab plus chemotherapy is a first-line treatment option in metastatic KRAS and NRAS wild-type colorectal cancer (CRC) patients. No data are currently available on continuing anti-epidermal growth factor receptor (EGFR) therapy beyond progression. Patients and methods: We did this open-label, 1:1 randomized phase II trial at 25 hospitals in Italy to evaluate the efficacy of cetuximab plus 5-fluorouracil, folinic acid and oxaliplatin (FOLFOX) as second-line treatment of KRAS exon 2 wild-type metastatic CRC patients treated in first line with 5-fluorouracil, folinic acid and irinotecan (FOLFIRI) plus cetuximab. Patients received FOLFOX plus cetuximab (arm A) or FOLFOX (arm B). Primary end point was progressionfree survival (PFS). Tumour tissues were assessed by next-generation sequencing (NGS). This report is the final analysis. Results: Between 1 February 2010 and 28 September 2014, 153 patients were randomized (74 in arm A and 79 in arm B). Median PFS was 6.4 [95% confidence interval (CI) 4.7-8.0] versus 4.5 months (95% CI 3.3-5.7); [hazard ratio (HR), 0.81; 95% CI 0.58-1.12; P = 0.19], respectively. NGS was performed in 117/153 (76.5%) cases; 66/117 patients (34 in arm A and 32 in arm B) had KRAS, NRAS, BRAF and PIK3CA wild-type tumours. For these patients, PFS was longer in the FOLFOX plus cetuximab arm [median 6.9 (95% CI 5.5-8.2) versus 5.3 months (95% CI 3.7-6.9); HR, 0.56 (95% CI 0.33-0.94); P = 0.025]. There was a trend in better overall survival: median 23.7 [(95% CI 19.4-28.0) versus 19.8 months (95% CI 14.9-24.7); HR, 0.57 (95% CI 0.32-1.02); P = 0.056]. Conclusions: Continuing cetuximab treatment in combination with chemotherapy is of potential therapeutic efficacy in molecularly selected patients and should be validated in randomized phase III trials